Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
4.0
3.8
Journals
Bioengineering
Special Issues
Chronic Kidney Disease: Diagnosis and Treatment
share announcement

Chronic Kidney Disease: Diagnosis and Treatment

A special issue of Bioengineering (ISSN 2306-5354). This special issue belongs to the section "Biomedical Engineering and Biomaterials".

Deadline for manuscript submissions: closed (30 April 2023) | Viewed by 15592

Special Issue Editors

Dr. Po-Jen Hsiao

E-Mail Website
Guest Editor
Division of Nephrology, Department of Internal Medicine, Taoyuan Armed Forces General Hospital, Taoyuan 325, Taiwan
Interests: chronic kidney disease; kidney bioengineering; proteinuria; albuminuria; hematuria; glomerular filtration rate; end-stage renal disease; kidney replacement therapy; dialysis; hemodialysis; peritoneal dialysis; kidney transplantation
Special Issues, Collections and Topics in MDPI journals
Prof. Dr. Chi-Ming Chu

E-Mail Website
Guest Editor
Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 114201, Taiwan
Interests: mHealth; wearable device; personal health record; eGFR correction; SNPs; GWAS; gene annotation; gene expression profile; natural language processing; artificial intelligence; biomedical informatics; biostatistics; epidemiology; public health
Special Issues, Collections and Topics in MDPI journals
Prof. Dr. Chi-Wen Chang

E-Mail Website
Guest Editor
School of Nursing, College of Medicine, Chang-Gung University, Taoyuan 333323, Taiwan
Interests: pediatrics nursing; pediatrics case management; chronic child care, e.g., asthma; diabetes type I; mHealth; health informatics; telematics; healthcare resource utilization
Special Issues, Collections and Topics in MDPI journals
Prof. Dr. Hao-Yun Kao

E-Mail Website
Guest Editor
Department of Healthcare Administration and Medical Informatics, College of Health Sciences, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
Interests: health informatics; telematics; healthcare resource utilization
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Chronic kidney disease (CKD) is defined as decreased kidney function shown by glomerular filtration rate (GFR) of less than 60 mL/min/1.73 m², or the presence of one or more markers of kidney damage (e.g., albuminuria, proteinuria, hematuria, urine sediment abnormalities, electrolyte abnormalities due to tubular disorders, abnormalities on histology, structural abnormalities detected by imaging, or history of kidney transplantation), and at least 3 months of duration. CKD can arise from many different disease pathways that deteriorate renal function irreversibly over months or years, while diabetes mellitus and hypertension are the main causes of CKD worldwide.

Treatment strategies for CKD patients usually consist of the management of diabetes mellitus and hypertension, avoiding nephrotoxins, adjustment in drug dosing, reducing risk of cardiovascular disease, diet adjustment, and treating complications. When the GFR is less than 15 mL/min/1.73m², the patient has reached end-stage renal disease (ESRD). Kidney function is no longer able to cope with waste and fluid clearance. Options for patients with ESRD are kidney replacement therapy (dialysis or kidney transplantation) or conservative care, that is, palliation or non-dialytic care.

This Special Issue of Bioengineering on "Chronic Kidney Disease: Diagnosis and Treatment" is dedicated to original papers, brief reports and reviews that provide further understanding or novel opinions in the diagnosis and treatment of CKD. For scholars, the traditional cell-culture models may not be adequate for studying the functional intricacies of the kidney. Recent experiments have offered improvements in our understanding of these systems, including organoid modeling, 3D bioprinting, decellularization, microfluidics and other potential applications of kidney bioengineering. We look forward to your valued research to make this Special Issue a reference resource.

Dr. Po-Jen Hsiao
Prof. Dr. Chi-Ming Chu
Prof. Dr. Chi-Wen Chang
Prof. Dr. Hao-Yun Kao
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • kidney bioengineering
  • chronic kidney disease (CKD)
  • glomerular filtration rate (GFR)
  • end-stage renal disease (ESRD)
  • kidney injury
  • nephrotoxins
  • kidney replacement therapy
  • kidney transplantation

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (4 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Review

13 pages, 1781 KiB  
Article
Performance of Nuclear Magnetic Resonance-Based Estimated Glomerular Filtration Rate in a Real-World Setting
by Amauri Schwäble Santamaria, Marcello Grassi, Jeffrey W. Meeusen, John C. Lieske, Renee Scott, Andrew Robertson and Eric Schiffer
Bioengineering 2023, 10(6), 717; https://doi.org/10.3390/bioengineering10060717 - 13 Jun 2023
Viewed by 1563
Abstract
An accurate estimate of glomerular filtration rate (eGFR) is essential for proper clinical management, especially in patients with kidney dysfunction. This prospective observational study evaluated the real-world performance of the nuclear magnetic resonance (NMR)-based GFRNMR equation, which combines creatinine, cystatin C, valine, [...] Read more.
An accurate estimate of glomerular filtration rate (eGFR) is essential for proper clinical management, especially in patients with kidney dysfunction. This prospective observational study evaluated the real-world performance of the nuclear magnetic resonance (NMR)-based GFRNMR equation, which combines creatinine, cystatin C, valine, and myo-inositol with age and sex. We compared GFRNMR performance to that of the 2021 CKD-EPI creatinine and creatinine-cystatin C equations (CKD-EPI2021Cr and CKD-EPI2021CrCys), using 115 fresh routine samples of patients scheduled for urinary iothalamate clearance measurement (mGFR). Median bias to mGFR of the three eGFR equations was comparably low, ranging from 0.4 to 2.0 mL/min/1.73 m2. GFRNMR outperformed the 2021 CKD-EPI equations in terms of precision (interquartile range to mGFR of 10.5 vs. 17.9 mL/min/1.73 m2 for GFRNMR vs. CKD-EPI2021CrCys; p = 0.01) and accuracy (P15, P20, and P30 of 66.1% vs. 48.7% [p = 0.007], 80.0% vs. 60.0% [p < 0.001] and 95.7% vs. 86.1% [p = 0.006], respectively, for GFRNMR vs. CKD-EPI2021CrCys). Clinical parameters such as etiology, comorbidities, or medications did not significantly alter the performance of the three eGFR equations. Altogether, this study confirmed the utility of GFRNMR for accurate GFR estimation, and its potential value in routine clinical practice for improved medical care. Full article
(This article belongs to the Special Issue Chronic Kidney Disease: Diagnosis and Treatment)
►▼ Show Figures

Figure 1

19 pages, 877 KiB  
Article
From Bench to Bedside: Clinical and Biomedical Investigations on Hepatitis C Virus (HCV) Genotypes and Risk Factors for Albuminuria
by Po-Jen Hsiao, Chia-Jen Hsiao, Fu-Ru Tsai, Yen-Lin Hou, Chih-Chien Chiu, Wen-Fang Chiang, Kun-Lin Wu, Yuan-Kuei Li, Chen Lin, Jenq-Shyong Chan, Chi-Wen Chang and Chi-Ming Chu
Bioengineering 2022, 9(10), 509; https://doi.org/10.3390/bioengineering9100509 - 27 Sep 2022
Cited by 4 | Viewed by 2226
Abstract
An extrahepatic manifestation of nephropathies can be a feature of the chronic hepatitis C virus (HCV) infection. Albuminuria is a major risk factor for nephropathies and chronic kidney disease (CKD). The correlation between HCV genotypes and albuminuria is still unclear. In this study, [...] Read more.
An extrahepatic manifestation of nephropathies can be a feature of the chronic hepatitis C virus (HCV) infection. Albuminuria is a major risk factor for nephropathies and chronic kidney disease (CKD). The correlation between HCV genotypes and albuminuria is still unclear. In this study, investigations have been done for the biomedical tools and methodologies used in the National Health and Nutrition Examination Survey (NHANES) public database. We searched the 2007–2016 NHANES public database to retrieve data regarding the different HCV genotypes and clinical scenarios. This study attempted to investigate the impacts of HCV genetic diversity, associated comorbidities, and racial differences on albuminuria. The urine albumin/creatinine ratio (ACR) was the primary endpoint. Among 40,856 participants, 336 participants with positive and 237 with negative HCV RNA tests were analyzed, excluding 14,454 participants with negative HCV antibodies and 25,828 which were missed. After controlling for sex, race, education level, smoking, diabetes mellitus, hepatitis B, alcohol use, and body mass index (BMI) with a generalized linear equation, HCV genotype 2 was more likely than any other genotype to cause albuminuria based on the urine ACR (p < 0.001). The generalized linear equation also demonstrated a significantly higher urine ACR, including hepatitis B (p < 0.001), diabetes mellitus (p < 0.001), and smoking (p = 0.026). In summary, the patients with HCV genotype 2 presented with increased albuminuria in comparison with other HCV genotypes in this 10-year retrospective analysis. HCV infection could be a risk factor of CKD; early diagnosis and appropriate treatment may improve clinical outcomes. Full article
(This article belongs to the Special Issue Chronic Kidney Disease: Diagnosis and Treatment)
►▼ Show Figures

Figure 1

Review

Jump to: Research

14 pages, 900 KiB  
Review
Revisiting the Role of NAG across the Continuum of Kidney Disease
by Ruder Novak, Grgur Salai, Stela Hrkac, Ivana Kovacevic Vojtusek and Lovorka Grgurevic
Bioengineering 2023, 10(4), 444; https://doi.org/10.3390/bioengineering10040444 - 4 Apr 2023
Cited by 7 | Viewed by 2745
Abstract
Acute and chronic kidney diseases are an evolving continuum for which reliable biomarkers of early disease are lacking. The potential use of glycosidases, enzymes involved in carbohydrate metabolism, in kidney disease detection has been under investigation since the 1960s. N-acetyl-beta-D-glucosaminidase (NAG) is a [...] Read more.
Acute and chronic kidney diseases are an evolving continuum for which reliable biomarkers of early disease are lacking. The potential use of glycosidases, enzymes involved in carbohydrate metabolism, in kidney disease detection has been under investigation since the 1960s. N-acetyl-beta-D-glucosaminidase (NAG) is a glycosidase commonly found in proximal tubule epithelial cells (PTECs). Due to its large molecular weight, plasma-soluble NAG cannot pass the glomerular filtration barrier; thus, increased urinary concentration of NAG (uNAG) may suggest injury to the proximal tubule. As the PTECs are the workhorses of the kidney that perform much of the filtration and reabsorption, they are a common starting point in acute and chronic kidney disease. NAG has previously been researched, and it is widely used as a valuable biomarker in both acute and chronic kidney disease, as well as in patients suffering from diabetes mellitus, heart failure, and other chronic diseases leading to kidney failure. Here, we present an overview of the research pertaining to uNAG’s biomarker potential across the spectrum of kidney disease, with an additional emphasis on environmental nephrotoxic substance exposure. In spite of a large body of evidence strongly suggesting connections between uNAG levels and multiple kidney pathologies, focused clinical validation tests and knowledge on underlining molecular mechanisms are largely lacking. Full article
(This article belongs to the Special Issue Chronic Kidney Disease: Diagnosis and Treatment)
►▼ Show Figures

Figure 1

22 pages, 1559 KiB  
Review
Hemodiafiltration: Technical and Medical Insights
by Thomas Lang, Adam M. Zawada, Lukas Theis, Jennifer Braun, Bertram Ottillinger, Pascal Kopperschmidt, Alfred Gagel, Peter Kotanko, Manuela Stauss-Grabo, James P. Kennedy and Bernard Canaud
Bioengineering 2023, 10(2), 145; https://doi.org/10.3390/bioengineering10020145 - 21 Jan 2023
Cited by 20 | Viewed by 6959
Abstract
Despite the significant medical and technical improvements in the field of dialytic renal replacement modalities, morbidity and mortality are excessively high among patients with end-stage kidney disease, and most interventional studies yielded disappointing results. Hemodiafiltration, a dialysis method that was implemented in clinics [...] Read more.
Despite the significant medical and technical improvements in the field of dialytic renal replacement modalities, morbidity and mortality are excessively high among patients with end-stage kidney disease, and most interventional studies yielded disappointing results. Hemodiafiltration, a dialysis method that was implemented in clinics many years ago and that combines the two main principles of hemodialysis and hemofiltration—diffusion and convection—has had a positive impact on mortality rates, especially when delivered in a high-volume mode as a surrogate for a high convective dose. The achievement of high substitution volumes during dialysis treatments does not only depend on patient characteristics but also on the dialyzer (membrane) and the adequately equipped hemodiafiltration machine. The present review article summarizes the technical aspects of online hemodiafiltration and discusses present and ongoing clinical studies with regards to hard clinical and patient-reported outcomes. Full article
(This article belongs to the Special Issue Chronic Kidney Disease: Diagnosis and Treatment)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-4
Back to TopTop